Home » Topics » Conferences

Conferences
RSS

Minimum effective dose of licostinel determined in rat model of transient focal cerebral ischemia

June 4, 1998

Farnesyltransferase inhibitor with potential in the treatment of glioblastoma multiforme

June 4, 1998

Transurethral alprostadil: conflicting results presented at AUA meeting

June 3, 1998

Vasomax phase III results presented at AUA meeting

June 3, 1998

Nibentan, a potentially safer class III antiarrhythmic agent

June 2, 1998

Venlafaxine: cause of cardiac toxicity identified

June 2, 1998

SR-146131, the most potent CCK-A receptor agonist reported to date

June 2, 1998

NHE inhibition with dietary cariporide proves beneficial in infarct model

June 2, 1998

EMD-96785: a promising cardioprotective agent from Merck KGaA

June 2, 1998

Hemodynamic and electrophysiological effects of S-16257 assessed in dogs

June 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...